Education
About Us
Working with TipRanks
Follow Us
Vivos (RDGL)
:RDGL
Vivos News
Options Prices
Currently, No data available
---
Ownership Overview
2.30% Insiders
―
Mutual Funds
― Other Institutional Investors
97.70% Public Companies and
Individual Investors
RDGL FAQ
What was Vivos ’s price range in the past 12 months?
Vivos lowest stock price was $0.06 and its highest was $0.26 in the past 12 months.
What is Vivos ’s market cap?
Vivos ’s market cap is $56.01M.
When is Vivos ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vivos ’s earnings last quarter?
Currently, no data Available
Is Vivos overvalued?
According to Wall Street analysts Vivos ’s price is currently Overvalued.
Does Vivos pay dividends?
Vivos does not currently pay dividends.
What is Vivos ’s EPS estimate?
Vivos ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vivos have?
Vivos has 453,512,240 shares outstanding.
What happened to Vivos ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vivos ?
Currently, no hedge funds are holding shares in RDGL
Vivos Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
RDGL Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $7.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.9%
Last 30 Days ▲ 11.9%
Last 30 Days ▲ 11.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-27.64%
12-Months-Change
Fundamentals
Return on Equity
-141.81%
Trailing 12-Months
Asset Growth
138.86%
Trailing 12-Months
Company Description
Vivos
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.